Broadcasting News

Namgoong Min and Jin Ah-reum Become Parents Four Years After Marriage… Welcome a Son

"Difficult to Verify Details"

Gim Ga Yeong
2026-07-27 08:39:17
[Edaily Starin Gim Ga Yeong Reporter] Actors Namgoong Min and Jin Ah-reum have become parents four years after their marriage.
Namgoong Min (left) and Jin Ah-reum (Photo courtesy of their agency)
A representative from Namgoong Min’s agency, 935 Entertainment, told Edaily on the 27th, “The couple has welcomed a son,” adding, “As this concerns their private life, we ask for your understanding that we cannot provide further details.”
Namgoong Min made his debut in 2001 with the film *Bungee Jumping of Their Own* and has since appeared in dramas such as *Manager Kim*, *Stove League*, *The 1,000-Won Lawyer*, and *Lovers*. He is currently starring in the KBS2 drama *The Perfection of Marriage*.
Jin Ah-reum debuted as a model in 2008 and has since appeared in films such as “The Fixer” and “The Royal Tailor.”
After dating for seven years, the couple tied the knot in 2022.

Economy

Corporation

IT·Science

Economy

"AI Broadcasts on Its Own"... A Creator Startup Founded by a Former TikTok Employee [VC Cradle]

A virtual creator that doesn’t require a human actor has emerged. There is no pre-written script, nor is there an operator manipulating it in real time. Artificial intelligence (AI) hosts the broadcas…
2026-08-08 11:01:04

Corporation

Mezzion Pharma Co., Ltd. Simultaneously Improves Cysts and Kidney Function in ADPKD… “Moving Directly to Phase 2b Clinical Trials in Korea and the U.S.”

“When you examine the kidneys of mice with polycystic kidney disease, you can see large cysts. However, after administering Udenafil, a reduction in the size of these cysts was visible even to the nak…
2026-08-08 08:16:01

IT·Science

SK BIOPHARMACEUTICALS Soars on Cenobamate Growth… The Era of 45% Generic Drug Prices Begins [Weekly Bio Roundup]

(Graphic: Generative AI) During the first week of August (August 3–7), SK BIOPHARMACEUTICALS posted its best-ever quarterly earnings, driven by the growth of its new epilepsy drug “cenobamate.” Ad…
2026-08-08 08:31:03